Predicting the 10-Year Risks of Atherosclerotic Cardiovascular Disease in Chinese Population: The China-PAR Project (Prediction for Atherosclerotic Cardiovascular Disease (ASCVD) Risk in China)

CirculationPublished Risk prediction model development and validation study

Authors' conclusion

Our project developed effective tools with good performance for 10-year ASCVD risk prediction among a Chinese population that will help to improve the primary prevention and management of cardiovascular disease.

Study context

Population
Chinese adults, 4 contemporary Chinese cohortsderivation cohort
Participants
21,320 adults
Comparison
China-PAR equations vs Pooled Cohort Equations
Outcome
First ASCVD event (10-year risk prediction)
Follow-up
10 years
Methodological detailsprospective derivation cohort, external validation in 2 independent cohorts
  • Prospective derivation cohort
  • External validation in 2 independent cohorts

Performance

As reported in the abstract

Discrimination and calibration of China-PAR equations · over 12 years of follow-up
Test or modelC statisticCalibration χ2
Men0.794 (95% CI 0.775-0.814)13.1 (P=0.16)
Women0.811 (95% CI 0.787-0.835)12.8 (P=0.17)

C statistic

Men0.794 (95% CI 0.775-0.814)
Women0.811 (95% CI 0.787-0.835)

Calibration χ2

Men13.1 (P=0.16)
Women12.8 (P=0.17)
First ASCVD event in derivation cohort
1048

Further findings

Internal and external validation

Good internal and external validation (external cohorts n = 14 123 and 70 838)

Comparison with Pooled Cohort Equations

Pooled Cohort Equations had lower C statistics and much higher calibration χ2 values in men

Original publication

Predicting the 10-Year Risks of Atherosclerotic Cardiovascular Disease in Chinese Population: The China-PAR Project (Prediction for ASCVD Risk in China). Circulation. Published 28 September 2016. doi:10.1161/circulationaha.116.022367

Summarised from the published abstract; every number is checked against it

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.